WO2010124286A1 - Flexible devices - Google Patents
Flexible devices Download PDFInfo
- Publication number
- WO2010124286A1 WO2010124286A1 PCT/US2010/032427 US2010032427W WO2010124286A1 WO 2010124286 A1 WO2010124286 A1 WO 2010124286A1 US 2010032427 W US2010032427 W US 2010032427W WO 2010124286 A1 WO2010124286 A1 WO 2010124286A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- helical
- stent
- strut member
- elements
- strut
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/823—Stents, different from stent-grafts, adapted to cover an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/825—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91516—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
Definitions
- the present invention relates generally to expandable tubular structures capable of insertion into small spaces in living bodies and, more particularly, concerns a stent or stent-like structure which is capable of substantial and/or repeated flexing at points along its length either in the compressed or deployed configuration without mechanical failures and with no substantial changes in its geometry.
- a stent is a tubular structure that, in a radially compressed or crimped state, may be inserted into a confined space in a living body, such as an artery or other vessel. After insertion, the stent may be expanded radially to enlarge the space in which it is located. Stents are typically characterized as balloon-expanding (BX) or self-expanding (SX).
- BX balloon-expanding
- SX self-expanding
- a balloon-expanding stent requires a balloon, which is usually part of a delivery system, to expand the stent from within and to dilate the vessel.
- a self expanding stent is designed, through choice of material, geometry, or manufacturing techniques, to expand from the crimped state to an expanded state once it is released into the intended vessel. In certain situations higher forces than the expanding force of the self expanding stent are required to dilate a diseased vessel. In this case, a balloon or similar device might be employed to aid the expansion
- Stents are typically used in the treatment of vascular and non-vascular diseases. For instance, a crimped stent may be inserted into a clogged artery and then expanded to restore blood flow in the artery. Prior to release, the stent would typically be retained in its crimped state within a catheter and the like. Upon completion of the procedure, the stent is left inside the patient's artery in its expanded state. The health, and sometimes the life, of the patient depend upon the stent's ability to remain in its expanded state. Stents and stent-like devices, while often used as permanent implants, can be used as temporary medical devices or components to be implanted in the body.
- stents are flexible in their crimped state in order to facilitate the delivery of the stent, for example within an artery. Few are flexible after being deployed and expanded. Yet, after deployment, in certain applications, a stent may be subjected to substantial flexing or bending, axial compressions and repeated displacements at points along its length, for example, when stenting the superficial femoral artery. This can produce severe strain and fatigue, resulting in failure of the stent.
- Stent-like structures are similar in construction as a stent such that they can compress to a smaller diameter or dimension, and can then expand in the body to a larger diameter or dimension.
- Stent-like devices are also placed in a vessel including arteries, veins ducts, esophagus, urinary tracts, urethra and colon.
- the stent or stent-like devices may support the vessel, act as a biased force, hold another component in place either temporarily or permanently, act as an anchor, prevent tissue or other bio material prolapse and block or divert flow.
- stent-like devices may be used to keep a vessel open or to open a vessel, act as a biased force, hold another component in place either temporarily or permanently, act as an anchor, block flow or divert flow. In some cases, they may be used in part to hold another item, device or component in place.
- An example would be a stent-like structure used with other components in a catheter-based valve delivery system. Such a stent-like structure holds a valve which is placed in a vessel.
- a second example would be a stent-like structure used to divert flow as may be needed in treatment of an aneurysm.
- a third example would be a stent-like structure used to anchor another device or component.
- a fourth example would be a stent-like structure to aid in the revascularization of a vessel which has expanded or otherwise become misshapen from an aneurysm, weak vessel wall or other cause.
- a fifth example would be a bifurcation device such as an abdominal aortic aneurysm device where the construction would have at least one section with the stent-like structure discussed herein.
- a stent will refer to both a stent and a stent- like device unless otherwise noted.
- a stent or a stent-like structure is constructed to have different types of tubular portions along its length.
- there are strut portions and helical portions where the strut portions are constructed primarily to provide radial expansion and radial strength, and the helical portions are constructed primarily to permit repeated flexing and axial compression and expansion.
- both the struts and helical portions, and the integration of the two typically contribute to all of the stent attributes.
- the flexing and axial compression are likely to be required simultaneously, so the stent structure permits repeated and substantial flexing while in an axially compressed or expanded state, and it permits axial compression while in a flexed state.
- strut portions are provided between helical portions or helical portions are provided between strut portions.
- the stent is self-expanding and strut portions and helical portions alternate along the length of the stent.
- the stents when used in pair can have helical strut portions which are mirrored images of each other or where the helical strut portions just have an opposite pitch.
- the connecting elements can be helical coils which form the helical portion or can be made of other connecting elements that are helical, straight or undulating in structure.
- the stent is preferably constructed so that, in the expanded state the helical portions permit axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about twice the average diameter of the device (preferably between 1.5 to 2.5 the average diameter of the device or component).
- a helical portion is made of joining elements which extend helically about the axis of the stent between locations on two different strut portions.
- a joining element is bi-directional, in that it extends first in one circumferential direction and then the other between the two locations and has a peak, and the circumferential distance of the peak from a location is more than approximately 15% (preferably between 10% and 20%) of the circumference of the stent when it is in its expanded state.
- the helical portions are constructed to permit axial compression or expansion of about 30% and simultaneously permit bending with a minimum bending radius equal to about twice the average diameter of the device or component.
- a helical portion is made of joining elements which extend helically about the axis of the stent between points on two different strut portions which are spaced apart circumferentially by a distance which is more than approximately 25% (preferably 20% to 30%) of the circumference of the stent when it is in its expanded state.
- the stent has a main body defined by an axial sequence of helical segments lying about the stent axis and each defining a complete turn of the helix.
- the two strut portions between which a helical portion extends include adjacent helical segments.
- a helical portion is made of joining elements which extend helically about the axis of the stent between points on two strut portions which are spaced apart circumferentially by a distance which is more than approximately 25% (preferably between 20% and 30%) of the circumference of the stent when it is in its expanded state.
- the main body may include an elongated element extending generally helically about the stent axis and having a series of wave-like struts extending along its length.
- a joining element is connected between struts on adjacent strut portions which are spaced apart circumferentially by a distance which is greater than approximately twice the circumferential extent of a strut.
- a helical portion is made of helical elements which extend helically about the axis of the stent between points on two different strut portions which are spaced apart circumferentially by a distance which is more than approximately 25% (e.g. 20% to 30%), preferably more than approximately 50% (e.g. 40% to 60%) of the circumference of the stent (which is equivalent to an extent of 90 degrees about the axis of the stent) when it is in its expanded state.
- a helical portion is made of helical elements which extend helically about the axis of the stent between locations on two different strut portions.
- a helical element is bi-directional, in that it extends first in one circumferential direction and then the other between the two locations and has a peak.
- a stent has a plurality of axially spaced strut portions defining generally tubular axial segments of the stent and constructed to be radially expandable.
- a helical portion is interposed axially between two strut portions, and the helical portion has a plurality of helical elements connected between circumferentially spaced locations on two strut portions.
- a helical element extends helically between these locations, and at least part of the helical portion has a greater diameter than a strut portion when the stent is in an expanded state.
- at least part of the helical portion has a smaller diameter than the strut portion when the strut is in an expanded state.
- the helical element is wound at least 90 degrees between strut elements connected to the helical element. In another embodiment, the helical element is wound at least 360 degrees between strut elements connected to the helical element.
- stent grafts are formed of a biocompatible graft material covering the outside, inside or both the outside and inside of the stent.
- the stent graft can have any embodiment of a stent structure of the present invention. Stent graft devices are used, for example, in the treatment of aneurysms, dissections and tracheo- bronchial strictures.
- the stent can also be coated with a polymer and/or drug eluting material as are known in the art.
- a stent or stent like device is constructed at least in part such that the coils are placed as closely together as possible, the cell sizes are minimized, the metal-to-metal gaps are minimized and/or the metal coverage is maximized such that the device can in part divert flow in a vessel or could minimize vessel wall prolapse in a vessel with softer tissue, such as for treatment of saphenous vein graft disease, which may with a less dense construction squeeze between and protrude from the mesh.
- the construction of this embodiment could be such that the center or near the center is denser to cover, for example, the neck of an aneurysm or an artereovenous fistula.
- a stent or stent like device is constructed at least in part such that the coils are placed as closely together as possible, the cell sizes are minimized, the metal-to-metal gaps are minimized and/or the metal coverage is maximized such that the device can in part divert flow in a vessel.
- a second device is constructed similarly but has an opposite pitch as the first device. These two devices are intended to be implanted one right after the other or together such that they over lap at least in part to maximize the flow diversion. The second device can be longer, shorter, or the same length as the first device.
- the construction of this embodiment could be such that the center or near the center is denser to cover, for example, the neck of an aneurysm.
- the construction could be such that the stents are intended to overlap such that a portion of each stent extends out of the other stent. In any case, the intended area of overlap between the two devices is designed to maximize flow diversion.
- one device has an opposite pitch from a second device.
- the devices are used together to treat an AV fistula such that one device is placed in the artery of the AV fistula and one device is placed in the vein of the AV fistula.
- the two devices can be provided together in a kit or separately.
- a stent or stent like device pair is constructed such that each device has a helical strut with an opposite pitch from the other.
- the two devices can have helical coils connecting neighboring windings of the struts or other connecting links such as an undulating links or straight links.
- the two devices can be provided together in a kit or separately.
- a flow diverter type construction is shaped to have a dog bone type shape such that the inside diameter is less than the diameter at both ends.
- a stent or stent like device is constructed such that at least part of the center section is tubular and one end tapers down to a smaller diameter or a solid ring.
- Such an embodiment may be preferred for construction of a permanent or temporary filter or revascularization device.
- a stent or stent like device is constructed such that at least part of the center section is tubular and both ends taper down to a smaller diameter or a solid ring.
- the center tubular section may be relatively long or not be long at all forming almost a point at which the two ends join at a larger diameter.
- Such an embodiment may be preferred for construction of a permanent or temporary filter or revascularization device.
- a stent or stent like device is constructed such that valve material can be attached to the structure.
- valve material can be attached to the structure.
- a stent or stent like device is constructed such that the device can anchor itself or another device with sufficient radial strength, barbs, and/or tapered ends or mid-section.
- a stent or stent like device is used in the construction of a bifurcation device in at least one of the three legs.
- Fig. IA is a plan view of a first embodiment of a stent in accordance with the present invention, the stent being shown in an unexpanded state;
- FIG. IB is a plan view of the first embodiment of a stent in accordance with the present invention, the stent being shown in a radially expanded state;
- FIG. 2 is a plan view of a second embodiment of a stent in accordance with the present invention
- Fig. 3 is a plan view of a third embodiment of a stent in accordance with the present invention.
- FIG. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention.
- FIG. 5 is a sectional end view of a fifth embodiment of a stent in accordance with the present invention.
- Fig. 6 is a lengthwise side outline view of the same embodiment as Fig. 5;
- FIG. 7A is a plan view of another embodiment of a stent in accordance with the present invention.
- Fig. 7B is a plan view of another embodiment of the stent in accordance with the present invention.
- Fig. 8 is a sectional end view of another embodiment of the stent in accordance with the present invention.
- Fig. 9 is a lengthwise side outline view of the embodiment shown in Fig. 8;
- Fig. 1OA is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface of the stent;
- Fig. 1OB is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an inner surface of the stent;
- Fig. 1OC is a sectional end view of an alternate embodiment of a stent in accordance with the present invention including graft material covering an outer surface and an inner surface of the stent;
- FIG. 1 IA is a side view of an alternate embodiment of a stent in accordance with the present invention including graft material attached to the strut portion, the graft material covering the strut portion and the helical portion;
- Fig. HB is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material wherein a gap is provided between each of the sections of graft material;
- Fig. HC is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of a biocompatible graft material wherein the graft material of adjacent sections is overlapped;
- Fig. HD is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a bulge at the helical portions;
- Fig. HE is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material, the graft material having a plurality of longitudinal openings over the helical portions;
- FIG. 1 IF is a side view of an alternate embodiment of a stent in accordance with the present invention the graft material having a bulge at the helical portions and the graft material having a plurality of longitudinal openings over the helical portions;
- FIG. HG is a side view of an alternate embodiment of a stent in accordance with the present invention including a biocompatible graft material having a plurality of helical openings corresponding to a pitch of the helical elements;
- Fig. 1 IH is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material each of the sections being attached to either the strut portion or the helical portion wherein a gap is provided between each of the sections of graft material;
- Fig. 1 IJ is a side view of an alternate embodiment of a stent in accordance with the present invention including a plurality of sections of biocompatible graft material, each of the sections being attached to either the strut portion or the helical portion wherein adjacent sections of graft material is overlapped;
- Fig. 12A is a plan view of an alternate embodiment of a stent in an expanded state
- Fig. 12B is a plan view of the stent of Fig. 12A in a crimped state such that the gap between helical elements is the same throughout the helical portions. Additionally, the length of the stent is the same in both the crimped and expanded state;
- Fig. 12C is a plan view of the stent of Fig. 12A in a crimped state such that the gap between helical elements changes throughout the helical portion. Additionally, the stent is longer in the crimped state than the expanded state; and
- Fig. 13 is a plan view of an alternate embodiment of a stent in accordance with the present invention.
- Fig. 14 is a plan view of flow diverter or similar device for minimizing vessel wall prolapse.
- Fig. 15 is a plan view of a flow diverter or similar device for minimizing vessel wall prolapse with the opposite pitch of that in Fig. 14.
- Fig. 16 is a plan view of two flow diverters or similar device for minimizing vessel wall prolapse with opposite pitch overlapping.
- FIGS. 17A-17E are side profile views of flow diverters or similar device for minimizing vessel wall prolapse in different overlapping configurations.
- Figs 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A and Figs. 17A-17E are side profile views of flow diverters or similar device for minimizing vessel wall prolapse in different overlapping configurations.
- Figs 17A and Figs. 17A-17E are side profile views of flow diverters or similar device for minimizing vessel wall prolapse in different overlapping configurations.
- FIG. 17D are not overlapping.
- Fig. 17B overlaps at then ends of both devices.
- Fig.l7C two same length devices completely overlap.
- Fig. 17E a smaller stent is nested completed within a longer stent. The longer device could also be nested within the shorter devices
- Fig. 18 is a side view of a flow diverter or similar device for minimizing vessel wall prolapse with a dog-bone type shape.
- Figs. 19A-19B are side views of filters or revascularization devices.
- the cylindrical portion towards the center can have the stent-like construction described herein.
- the cylindrical portion could also be shaped more like a football or other similar shape.
- Fig. 20 is a side view of a bifurcation device such as an abdominal aortic aneurysm device.
- Figs. IA and IB are plan views of a first embodiment of stent 10 in accordance with the present invention shown in an unexpanded state and expanded state, respectively.
- the term "plan view” will be understood to describe an unwrapped plan view. This could be thought of as slicing open a tubular stent along a line parallel to its axis and laying it out flat. It should therefore be appreciated that, in the actual stent, the top edge of the Fig. IA will be joined to the lower edge.
- Stent 10 is made from a common material for self expanding stents, such as
- Nitinol nickel-titanium alloy Ni/Ti
- the stent is laser cut from tubing, for example, with a diameter of about 5mm (Fig. IA). It is then expanded and set to a diameter of about 8mm (Fig. IB), and for pre-deployment it would be crimped to a diameter appropriate for the application, for example about 2mm.
- Fig. IA diameter of about 5mm
- Fig. IB a diameter of about 8mm
- the present invention is applicable to any type and size of stent; and the present invention could be used for expansion ratios - ratio of expanded diameter or size to crimped diameter or size - much greater than that shown.
- Stent 10 is generally made up of strut portion 12 and helical portion 14 with axially aligned strut portion 12 alternating with helical portion 14.
- strut portion 12 is positioned at either end of stent 10.
- Strut portion 12 being radially expandable upon deployment.
- Each strut portion 12 includes strut ring 16 having a pattern of wave-like strut elements 16a that progresses circumferentially about the stent.
- Each strut element 16a has a width equal to the peak to peak distance around the stent and a length equal to the peak-to-peak distance along the length of the stent. It will be appreciated that strut ring 16 could be partially straightened (stretched vertically in Fig.
- the material of which stent 10 is made is such that strut element 16a will retain some wave-like shape in a radially expanded state.
- the stent would be crimped and fitted into a catheter, and it would expand after the catheter is inserted into the vessel and the stent is advanced out of the catheter.
- Each helical portion is made up of a plurality of side-by- side helical elements 18, each of which is helically wound about an axis of stent 10.
- Helical portion 14 is expandable radially upon deployment and compressible, expandable and bendable in a deployed state.
- Helical elements 18 can be connected between opposed individual wave portions of strut element 16a of different strut portions 12.
- each helical element 18 makes a complete rotation about the surface of stent 10. However, they can make a partial rotation or more than one rotation.
- the helical portion is preferably constructed to permit repeated axial compression or expansion of about 20% (preferably between 15% and 25%) and simultaneously permit bending with a minimum bending radius of about twice the average diameter of the device (preferably between 1.5 to 2.5 the average diameter of the device or component), all without failure.
- helical element 18 is wound at least 90 degrees between strut elements 16a connected to helical elements 18.
- helical element 18 is wound at least 360 degrees between strut elements 16a connected to helical elements 18.
- FIG. 2 is a plan view of a second embodiment of stent 20 similar to stent 10 of
- strut portions 12' The primary differences are in the structure of strut portions 12' and that there are right-handed and left-handed helical portions (14R and 14L, respectively).
- Each strut portion 12' comprises two adjacent strut rings 26, 27 connected by short link 28.
- the closely opposed peaks of strut elements 26a, 27a are connected by short link 28, so that each strut portion 12' has a double strut ring structure.
- twin or multiple strut ring strut portions is that they offer increased radial stiffness over the single strut ring strut portion and can stabilize the strut portions so they are less affected by axial forces.
- a right-handed helical portion 14R the elements 18 progress clockwise about the surface of stent 10 and, in a left-handed helical portion 14L, they progress counterclockwise.
- Helical elements 18 essentially float and permit relatively large displacements about and along the stent axis between the two strut ring portions at either end.
- the diameter of the stent at each helical portion 14R, 14L is the same as the diameter of the stent at the strut portions 12 on either side. However, this need not be the case, as will become evident from additional embodiments discussed below.
- Fig. 3 is another embodiment of stent 30 in accordance with the present invention. It is similar to stent 20 of Fig. 2, except that helical portions 34 include helical element 38 which progresses bi-directionally (first counterclockwise and then clockwise) about the perimeter of stent 30 between connection locations on two different strut portions 12'. Helical element 38 is wound at least 90 degrees from a first strut portion 12' to peak 35 and is wound 90 degrees from peak 35 to a second strut portion 12' in order to maintain flexibility.
- the one-directional helical elements 18 of Fig. IA and IB can allow adjacent strut portions to rotate relative to one another.
- the bi-directional helical elements 38 limit the amount adjacent strut portions can rotate about the stent axis relative to one another but still provide axial and bending flexibility.
- Fig. 4 is a plan view of a fourth embodiment of a stent in accordance with the present invention.
- stent 40 has strut portions 12' of Fig. 2 and the helical portions 14L, 14R (Fig. 2) and helical portions 34 (Fig. 3).
- the advantage of this construction is that combining different types of helical elements allows a mix of properties as described herein, providing the opportunity for further optimization of overall stent performance for a given application.
- Fig. 5 is a sectional view perpendicular to the axis of a fifth embodiment of stent 30' in accordance with the present invention
- Fig. 6 is a side outline view of the same embodiment.
- the stent has the structure shown in Fig. 3, except that helical portions 38' have a larger diameter than strut portions 12'. In this construction the radial stiffness of the helical portions is increased, but to a lesser degree than the strut portions.
- the helical portions may not have as much outward force on a vessel as the strut portions when the strut is expanded.
- the geometry of Fig. 6 will tend to force the helical portions to expand more than the strut portions, increasing the outward force of the helical portions, which equalizes the radial stiffness.
- Nitinol structures have a biased stiffness, such that the force required to collapse the structure back towards the collapsed state is generally greater than the force that continues to dilate the diseased vessel when the stent is in its expanded state.
- a balloon is used to assist the expansion/dilation of the vessel.
- the biased stiffness is enough to support the open vessel, but the outward force may not be enough to open the vessel (or it may take a longer period of time).
- a stent with the type of geometry shown in Fig. 5 would therefore be a good expedient to use in conjunction with balloon assisted expansion, or other applications requiring additional expansive force.
- Stent 4OB' includes strut member 42.
- Strut member 42 progresses helically from one end of stent 4OB' to the other.
- Strut member 42 forms main body of stent 4OB'.
- each strut element 44a is connected to a strut in a subsequent winding of strut member 42 by helical element 46.
- helical element 46 of helical portion 45 progresses helically less than one full rotation of 360 degrees about stent 4OB'.
- Helical element 46 progresses in a direction opposite of the direction of which strut member 42 progresses helically about stent 4OB'.
- helical elements 46 are axially abutted, forming a type of spring which permits a great deal of flexibility and axial expansion, while strut member 42 provides radial strength and retains the stent in its expanded condition.
- Fig. 7B is a plan view of another embodiment of stent 4OC in accordance with the present invention.
- Stent 4OC is similar to stent 4OB' and includes strut member 42.
- Strut member 42 progresses helically from one end of stent 4OC to the other.
- Strut member 42 forms main body of stent 4OC.
- each strut element 44a is connected to a strut in a subsequent winding of strut member 42 by helical element 47.
- helical element 47 progresses helically about stent 4OC in the same direction as strut member 42 progresses helically about stent 4OC.
- Stent 4OC includes transitional helical portions 49 and strut portions 48 at either end of stent 4OC to allow strut portion 48 to be provided at either end of stent 4OC.
- Stents 4OB' and 4OC have the advantage that the flexible helical elements are distributed more continuously along the length of the stent and may provide more continuous flexibility.
- stent 4OB' or 4OC various modifications to stent 4OB' or 4OC are possible, depending upon the requirements of a particular design. For example, it might be desirable to connect fewer than all of strut elements 44a in a particular winding to a subsequent winding, reducing the number of helical elements 46. Helical elements 46 can extend for less or for any integer or non-integer multiple of a rotation.
- a stent could also be made of a plurality of tubular sections each having the construction of stent 4OB' or 4OC and joined lengthwise by another type of section.
- Fig. 8 is a sectional view perpendicular to the axis of an embodiment of stent 20' in accordance with the present invention
- Fig. 9 is a side outline view of the same embodiment.
- the stent has the structure shown in Fig. IA, except that helical portions 14' neck down to a smaller diameter than strut portions 12'. In this construction the helical portions will exert less force on the vessel wall than if the helical portions were the same diameter. Reducing the force the stent exerts on a vessel wall can reduce the amount of damage done to a vessel and provide a better performing stent.
- Figs. 10A- 1OC are sectional views perpendicular to the axis of the stent in accordance with the present invention.
- Stent graft 60, 70 and 80 have a stent structure of the present invention of any of the embodiments described above with helical portions interposed between strut portions.
- biocompatible graft material 62 covers outside 64 of stent graft 60, as shown in Fig. 1OA.
- biocompatible graft material 62 covers inside 74 of stent 70, as shown in Fig. 1OB.
- graft material 62 covers outside 64 and inside 74 of stent 80, as shown in Fig. 1OC.
- Graft material 62 can be formed of any number of polymers or other biocompatible materials that have been woven or formed into a sheet or knitted surface. Alternatively, the stent can be coated with a polymer and/or drug eluting material as are known in the art.
- Figs. 1 IA-I IJ are side profile views of stent grafts including the features of the flexible stent structure of the present invention.
- Stent graft 100 comprises a continuous covering of graft material 102 covering stent 10, as shown in Fig. HA. Graft material 102 is attached to strut portions 12. Graft material 102 covers and is not attached to helical portions 14.
- Stent graft 110 comprises a plurality of sections 111 of graft material 112 covering the stent structure, as shown in Fig. HB. Graft material 112 is attached to strut portions 12. Graft material 112 covers at least a portion of helical portions 14 and is not attached to helical portions 14. Gap 115 is positioned between adjacent sections 111 of graft material 112. Gap 115 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14.
- Stent graft 120 comprises a plurality of sections 121 of graft material 122 covering the stent structure, as shown in Fig. 11C. Graft material 122 is attached to strut portions 12. Graft material 122 covers and is not attached to helical portions 14.
- Sections 121 of graft material 122 are positioned such that there is an overlap 125 between adjacent sections 121 of graft material 122.
- Overlap 125 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14.
- Stent graft 130 comprises a continuous covering of graft material 132, as shown in Fig. HD. Graft material 132 is attached to strut portions 12. Graft material 132 covers and is not attached to helical portions 14. Graft material 132 has bulge 133 at helical portions 14.
- Stent graft 140 comprises a continuous covering of graft material 142, as shown in Fig. HE. Graft material 142 has a plurality of longitudinal openings 144 over helical portions 14.
- Stent graft 150 comprises a continuous covering of graft material 152, as shown in Fig. 1 IF.
- Graft material 152 has bulge 153 at helical portions 14 and has a plurality of longitudinal openings 154 over helical portions 14.
- Stent graft 160 comprises a continuous covering of graft material 162, as shown in Fig. HF. Graft material 162 has helical openings 164 in helical portions 14 that correspond to the pitch and angle of helical portions 14.
- Stent graft 170 comprises a plurality of sections 171 of graft material 172 covering stent 10, as shown in Fig. 1 IH. Sections 171 can be attached to strut portions 12 or helical portions 14. Gap 175 is positioned between adjacent sections 171 of graft material 172. Gap 175 will typically range in size between 0 (meaning no gap) and about 20% of the length of helical portion 14.
- Stent graft 180 comprises a plurality of sections 181 of graft material 182 covering stent 10, as shown in Fig. HJ. Sections 181 can be attached to strut portions 12 or helical portions 14. Sections 181 of graft material 182 are positioned such that there is an overlap 185 between adjacent sections 181 of graft material 182. Overlap 185 will typically range in size between 0 (meaning no gap) and about 40% of the length of helical portion 14. [0094] Figs. 12A, 12B and 12C are plan views of stent 200 in accordance with the present invention. Fig. 12A shows stent 200 in an expanded state with gap 202 between helical elements 18. Figs.
- FIG. 12B and 12C show stent 200 in two different compressed states.
- stent 200 is compressed such that gap 212 between side-by-side helical elements 18 is about the same throughout helical portion 14.
- the size of gap 212 between side-by-side helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in Fig. 12A. In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another.
- stent 200 is compressed such that helical element 18 is elongated and gap 222 between side-by- side helical elements 18 varies throughout the axial length of helical portion 14.
- the size of gap 222 between adjacent helical elements 18 can range between 0 and about the size of the gap 202 in the expanded state, for example, as shown in Fig. 12A. In other words, when the size of the gap is 0, there is no space between side-by-side helical elements 18 and side-by-side helical elements 18 contact one another.
- the overall length 221 of the stent in the crimped state is greater then the overall length 201 of the stent in the expanded state.
- An additional method can be provided to crimp the stent such that the length of helical portions is shorter in the crimped state than in the expanded state. For example, if the stent of Fig. 12A were crimped similar to that shown in Fig. 12B, except no gap exists between side-by- side helical elements the stent would be have length 211 in the crimped state which is shorter than length 201 in the expanded state.
- a method of crimping provides a stent where the overall length is the same in the crimped and expanded state and there is no gap between helical elements in the crimped state.
- one preferred embodiment of the stent is to permit repeated axial compression or expansion of about 20% and simultaneously permit bending with a twice the average diameter of the device.
- One method to construct a stent of the present invention with a specific target for flexibility is to vary the ratio between the sum of the gap space in the helical portion to the overall length. By increasing that ratio, the flexibility of the stent increases. This ratio will also be approximately the maximum axial compression the stent will allow. It will be appreciated that the maximum axial compression for safety may be limited by other factors such as strain in the helical elements.
- Fig. 13 is a plan view of a stent 300 in accordance with the present invention.
- Stent 300 is similar to other embodiments described above except it includes various configurations and various axial lengths of strut portions and various configurations and various axial lengths of helical portions.
- Strut portions 302 positioned at the outer most portion of stent 300 includes long strut elements 301.
- Long strut elements 301 have length 311. Length 311 of long strut element 301 is greater than length 312 of strut portions 304 positioned at the inner portion of stent 300.
- Long strut elements 301 provided on the ends of the stent may be advantageous to provide better anchoring and provide an area for adjacent stents to overlap, but not impede the flexibility of the helical portion.
- the length of diseased artery may be long, often longer than 10 cm.
- Multiple stents may be required to treat these long sections of diseased arteries.
- a common procedure in this case is to overlap the adjacent stents so that the vessel being treated is covered.
- Helical portion 303 that is adjacent to the strut portion 302 comprises helical elements 18 that are connected to every strut element 301 of strut portion 302.
- Helical portion 303 can provide a high percentage of surface area for optimized delivery of a drug or other therapeutic agent.
- Strut portion 304 is connected to helical portion 303 by helical element 18 at every strut element 16a on side 320 of strut portion 304 and is connected to helical portion 309 at every other strut element 16a on side 321 of strut portion 304.
- Helical portion 309 provides a lower percentage of surface area and greater flexibility than helical portion 303. This type of configuration can provide a transition from a stiffer helical portion that has a high percentage of surface area to a more flexible helical portion.
- Helical portion 309 has a higher ratio of the sum of gap lengths 323 to length 324 of helical portion 309 than the sum of gap lengths 325 to length 326 of helical portion 303, so that helical portion 309 will generally have greater flexibility.
- Strut portion 306 has half as many strut elements 305 as strut portions 302 or 304 and therefore generally has more open area compared to strut portion 302 or strut portion 304.
- An advantage of a stent including a portion having a larger open area than other portions of the stent is that the larger open portion of the stent can be placed over an arterial bifurcation and not impede blood flow. Whereas the strut portion with a higher strut element density may impede blood flow.
- the stent structure of the present invention namely flexible helical portions flanked on either side by strut portions, provide an optimized structure where the strut portions stabilize a naturally unstable helical structure, and the helical portions provide net flexibility. There is substantial design optimization potential in combining various embodiments of the two portions.
- the flexible stents and stent grafts of the present invention may be placed within vessels using procedures well known in the art.
- the flexible stents and stent grafts may be loaded into the proximal end of a catheter and advanced through the catheter and released at the desired site.
- the flexible stents and stent grafts may be carried about the distal end of the catheter in a compressed state and released at the desired site.
- the flexible stents or stent grafts may either be self-expanding or expanded by means such as an inflatable balloon segment of the catheter. After the stent(s) or stent graft(s) have been deposited at the desired intralumenal site, the catheter is withdrawn.
- the flexible stents and stent grafts of the present invention may be placed within body lumen such as vascular vessels or ducts of any mammal species including humans, without damaging the lumenal wall.
- the flexible stent can be placed within a lesion or an aneurysm for treating the aneurysm.
- the flexible stent is placed in a super femoral artery upon insertion into the vessel, the flexible stent or stent grafts provides coverage of at least about 50% of the vessel.
- Fig. 14 is a plan view of a stent 400 in accordance with the present invention.
- Stent 400 is similar to Stent 4OB'. Stent 400 has strut portion 401 and helical portion 402.
- Fig. 15 is a plan view of a stent 500 in accordance with the present invention.
- Stent 500 is similar to stent 400. Stent 500 has a helical pitch in the opposite direction of stent 400.
- Fig. 16A is a plan view of stent 400 and stent 500 predominantly overlapping each other providing a crossing of features which create smaller openings as compared to one stent alone.
- Fig. 16B is a side view of Stent 400 and Stent 500 predominantly overlapping each other showing the coverage across aneurysm 550 with length of 16 mm.
- FIGs. 17A-17E are side profile views of flow diverters or similar device for minimizing vessel wall prolapse in different overlapping configurations in accordance with the present invention.
- Figs 17A illustrates non-overlapping flow diverter 600 having a helical pitch of stent 601 in an opposite direction to stent 602.
- FIG. 17B illustrates flow diverter 700 having a helical pitch of stent 701 in an opposite direction to stent 702. End 703 of stent 701 overlaps end 704 of stent 702 in central portion 705. Flow diverter 700 does not overlap at ends 706a, 706b.
- Fig.l7C illustrates flow diverter 800 having a helical pitch of stent 801 in an opposite direction to stent 802.
- Stent 801 has the same length as stent 802.
- Stent 801 completely overlaps stent 802.
- Fig 17D illustrates non-overlapping flow diverter 900 having a helical pitch of stent 901 in an opposite direction to stent 902.
- Stent 901 has a shorter length than stent 902.
- FIG. 17E illustrates flow diverter 1000 having a helical pitch of Stent 1001 in an opposite direction to Stent 1002.
- Stent 1002 is shorter than Stent 1001.
- the figure demonstrates both Stent 1002 is completely nested within Stent 1001, or Stent 1001 is completely nested within Stent 1002.
- Fig. 18 is a side view of a flow diverter 1100 or similar device for minimizing vessel wall prolapse with a dog-bone type shape. Ends 1102a, 1102b have a larger diameter than central portion 1104. The alternate strut portions and helical portions extends within the central portion 1104
- Figs. 19A-19B are side views of filters or revascularization devices.
- Fig. 19A illustrates device 1200.
- Device 1200 has a tapered end 1201 than a larger central portion 1202.
- Central portion 1202 can be formed to be predominantly cylindrical. Alternatively, central portion 1202 can be shaped more like a football or other similar shape.
- the alternate strut portions and helical portions extends within the central portion 1204.
- Device 1300 has tapered ends 1301a and 1301b than a larger central portion 1302.
- Central portion 1302 can be formed to be predominantly cylindrical. Alternatively, central portion 1302 can be shaped more like a football or other similar shape.
- the alternate strut portions and helical portions extends within the central portion 1304.
- FIG. 20 is side views of a bifurcation device 1400 where each of the legs of the device 1401, 1402 and 1403 can be constructed of a stent-like device described herein.
- a single leg or two legs could be constructed of a stent-like device described herein.
- any given leg could be constructed of a stent-like device or multiple stent-like devices described herein.
- Each leg can be formed in a predominantly cylindrical shape.
- Graft material can cover some or all of the device.
- the legs can be connected to each other with metal or graft material. Barbs can be added to the construction to assist in anchoring the device.
- a stent could be made with only right-handed or only left-handed helical portions, or the helical portions could have multiple reversals in winding direction rather than just one.
- the helical portions could have any number of turns per unit length or a variable pitch, and the strut rings and/or helical portions could be of unequal length along the stent.
- Devices intended for use in pairs could have helical strut portions with windings in opposite directions or could have section of device pairs intended to overlap with windings in opposite directions. Further, a device could have circumferential struts with helical sections interposed. Pairs of such devices could have sections intended to overlap in use with windings in opposite directions. All such devices intended for use together could be sold together in a kit or sold separately.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Carriages For Children, Sleds, And Other Hand-Operated Vehicles (AREA)
- Shaping Of Tube Ends By Bending Or Straightening (AREA)
- Moulding By Coating Moulds (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020117027875A KR101314224B1 (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
AU2010238636A AU2010238636A1 (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
EP10767889.8A EP2421470A4 (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
CA2759441A CA2759441A1 (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
CN201080017811.2A CN102413791B (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
RU2011147113/14A RU2011147113A (en) | 2009-04-24 | 2010-04-26 | SELF-EXTENDABLE AND EXPANDABLE FLEXIBLE DEVICES |
JP2012507471A JP2012524641A (en) | 2009-04-24 | 2010-04-26 | Flexible device |
MX2011011209A MX2011011209A (en) | 2009-04-24 | 2010-04-26 | Flexible devices. |
BRPI1013573A BRPI1013573A2 (en) | 2009-04-24 | 2010-04-26 | flexible devices |
NZ595936A NZ595936A (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
HK12108479.9A HK1167798A1 (en) | 2009-04-24 | 2012-08-29 | Flexible devices |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17248509P | 2009-04-24 | 2009-04-24 | |
US61/172,485 | 2009-04-24 | ||
US22696509P | 2009-07-20 | 2009-07-20 | |
US61/226,965 | 2009-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010124286A1 true WO2010124286A1 (en) | 2010-10-28 |
Family
ID=43011511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/032427 WO2010124286A1 (en) | 2009-04-24 | 2010-04-26 | Flexible devices |
Country Status (13)
Country | Link |
---|---|
US (2) | US20100286760A1 (en) |
EP (1) | EP2421470A4 (en) |
JP (1) | JP2012524641A (en) |
KR (1) | KR101314224B1 (en) |
CN (1) | CN102413791B (en) |
AU (1) | AU2010238636A1 (en) |
BR (1) | BRPI1013573A2 (en) |
CA (1) | CA2759441A1 (en) |
HK (1) | HK1167798A1 (en) |
MX (1) | MX2011011209A (en) |
NZ (1) | NZ595936A (en) |
RU (1) | RU2011147113A (en) |
WO (1) | WO2010124286A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2854718A4 (en) * | 2012-06-05 | 2016-02-24 | Merit Medical Systems Inc | Esophageal stent |
WO2016037115A1 (en) * | 2014-09-04 | 2016-03-10 | Boston Scientific Scimed, Inc. | Bioerodible polymeric stent scaffolding pattern |
WO2016065086A1 (en) * | 2014-10-22 | 2016-04-28 | Boston Scientific Scimed, Inc. | Stent with flexible hinge |
EP2967939A4 (en) * | 2013-03-14 | 2016-12-14 | Palmaz Scient Inc | Monolithic medical device, methods of making and using the same |
US9566633B2 (en) | 2012-11-15 | 2017-02-14 | Vactronix Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
US9700401B2 (en) | 2013-09-12 | 2017-07-11 | Boston Scientific Scimed, Inc. | Stent with anti-migration connectors |
US9713522B2 (en) | 2011-10-31 | 2017-07-25 | Merit Medical Systems, Inc. | Esophageal stent with valve |
WO2017165840A1 (en) * | 2016-03-24 | 2017-09-28 | Covidien Lp | Vascular flow diversion |
US10219921B2 (en) | 2014-10-02 | 2019-03-05 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
USD888245S1 (en) | 2014-03-14 | 2020-06-23 | Vactronix Scientific, Llc | Stent device |
US10898354B2 (en) | 2014-11-06 | 2021-01-26 | Boston Scientific Scimed, Inc. | Tracheal stent |
US11759341B2 (en) | 2020-01-13 | 2023-09-19 | Boston Scientific Scimed, Inc. | Anti-migration stent |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2505166B1 (en) * | 2005-04-04 | 2017-07-12 | Flexible Stenting Solutions, Inc. | Flexible stent |
US10159557B2 (en) | 2007-10-04 | 2018-12-25 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
US20150039072A1 (en) * | 2008-07-31 | 2015-02-05 | Bradley Beach | Flexible stent |
EP2640319B1 (en) | 2010-11-16 | 2016-10-19 | TriVascular, Inc. | Advanced endovascular graft and delivery system |
US10166128B2 (en) | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
US9839540B2 (en) | 2011-01-14 | 2017-12-12 | W. L. Gore & Associates, Inc. | Stent |
US9028540B2 (en) | 2011-03-25 | 2015-05-12 | Covidien Lp | Vascular stent with improved vessel wall apposition |
US10285798B2 (en) | 2011-06-03 | 2019-05-14 | Merit Medical Systems, Inc. | Esophageal stent |
US9072620B2 (en) * | 2011-11-04 | 2015-07-07 | Covidien Lp | Protuberant aneurysm bridging device deployment method |
US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US9254205B2 (en) | 2012-09-27 | 2016-02-09 | Covidien Lp | Vascular stent with improved vessel wall apposition |
US9931193B2 (en) | 2012-11-13 | 2018-04-03 | W. L. Gore & Associates, Inc. | Elastic stent graft |
US9629735B2 (en) | 2012-11-16 | 2017-04-25 | W. L. Gore & Associates, Inc. | Flexible endoluminal device |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
EP2964148A4 (en) | 2013-03-05 | 2016-08-24 | Merit Medical Systems Inc | Reinforced valve |
CN104936557A (en) | 2013-03-15 | 2015-09-23 | 美国医疗设备有限公司 | Esophageal stent |
DE102013104062A1 (en) * | 2013-04-22 | 2014-10-23 | Novatech Sa | stent |
US10842918B2 (en) | 2013-12-05 | 2020-11-24 | W.L. Gore & Associates, Inc. | Length extensible implantable device and methods for making such devices |
JP5695259B1 (en) | 2014-02-19 | 2015-04-01 | 株式会社World Medish | High flexibility stent |
WO2015142897A1 (en) * | 2014-03-18 | 2015-09-24 | Boston Scientific Scimed, Inc. | Reduced granulation and inflammation stent design |
JP6081948B2 (en) * | 2014-03-25 | 2017-02-15 | 株式会社World Medish Technology | Flexible stent |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
JP6688125B2 (en) * | 2015-03-31 | 2020-04-28 | 康宏 正林 | Highly flexible stent |
JP6734097B2 (en) * | 2015-03-31 | 2020-08-05 | 康宏 正林 | Highly flexible stent |
WO2016183128A1 (en) | 2015-05-11 | 2016-11-17 | Trivascular, Inc. | Stent-graft with improved flexibility |
EP4327787A3 (en) | 2015-05-27 | 2024-05-08 | TriVascular, Inc. | Balloon assisted endoluminal prosthesis deployment |
WO2017019913A1 (en) | 2015-07-30 | 2017-02-02 | Trivascular, Inc. | Endoluminal prosthesis deployment devices and methods |
US9592138B1 (en) | 2015-09-13 | 2017-03-14 | Martin Mayse | Pulmonary airflow |
EP4233806A3 (en) | 2016-04-21 | 2023-09-06 | W. L. Gore & Associates, Inc. | Diametrically adjustable endoprostheses |
WO2018107123A1 (en) | 2016-12-09 | 2018-06-14 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
CA3071133C (en) | 2017-09-12 | 2023-02-28 | W.L. Gore & Associates, Inc. | Leaflet frame attachment for prosthetic valves |
EP4364696A3 (en) | 2017-09-27 | 2024-07-03 | Edwards Lifesciences Corporation | Prosthetic valve with expandable frame and associated systems and methods |
AU2018342223B2 (en) | 2017-09-27 | 2021-04-01 | Edwards Lifesciences Corporation | Prosthetic valves with mechanically coupled leaflets |
CA3078699C (en) | 2017-10-13 | 2023-10-10 | W.L. Gore & Associates, Inc. | Telescoping prosthetic valve and delivery system |
CN107714244A (en) * | 2017-10-26 | 2018-02-23 | 柏为(武汉)医疗科技股份有限公司 | Vein blood vessel is from swollen support |
CA3205219A1 (en) | 2017-10-31 | 2019-05-09 | Edwards Lifesciences Corporation | Medical valve and leaflet promoting tissue ingrowth |
CN112292097B (en) | 2018-05-02 | 2024-07-23 | W.L.戈尔及同仁股份有限公司 | Expansion members for implantable devices and related systems and methods |
WO2020160476A2 (en) * | 2019-02-01 | 2020-08-06 | Bolton Medical, Inc. | Expandable luminal stents and methods of use |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
JP2023502997A (en) | 2019-11-19 | 2023-01-26 | ゼンフロー, インコーポレイテッド | Systems, devices and methods for accurate deployment and imaging of implants within the prostatic urethra |
AU2022314061A1 (en) * | 2021-07-20 | 2024-02-08 | Apreo Health, Inc. | Endobronchial implants and related technology |
WO2024054510A1 (en) * | 2022-09-07 | 2024-03-14 | Gianturco Michael C | Vascular stent connector, vascular stent-graft employing same, and methods of making same |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800526A (en) * | 1995-03-17 | 1998-09-01 | Endotex Interventional Systems, Inc. | Multi-anchor stent |
US20030195616A1 (en) * | 1994-03-17 | 2003-10-16 | Gregory Pinchasik | Articulated stent |
US20040002753A1 (en) * | 2002-06-28 | 2004-01-01 | Robert Burgermeister | Stent with diagonal flexible connecting links |
US6712842B1 (en) * | 1999-10-12 | 2004-03-30 | Allan Will | Methods and devices for lining a blood vessel and opening a narrowed region of a blood vessel |
WO2006108010A2 (en) | 2005-04-04 | 2006-10-12 | Burpee Materials Technology, Llc | Flexible stent |
US20070005126A1 (en) * | 2005-06-30 | 2007-01-04 | Boston Scientific Scimed, Inc. | Hybrid stent |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4307723A (en) * | 1978-04-07 | 1981-12-29 | Medical Engineering Corporation | Externally grooved ureteral stent |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4432132A (en) * | 1981-12-07 | 1984-02-21 | Bell Telephone Laboratories, Incorporated | Formation of sidewall oxide layers by reactive oxygen ion etching to define submicron features |
US5190546A (en) * | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4665906A (en) * | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US5275622A (en) * | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4740207A (en) * | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US5133732A (en) * | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5266073A (en) * | 1987-12-08 | 1993-11-30 | Wall W Henry | Angioplasty stent |
US6004330A (en) * | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
IE73670B1 (en) * | 1989-10-02 | 1997-07-02 | Medtronic Inc | Articulated stent |
US5190540A (en) * | 1990-06-08 | 1993-03-02 | Cardiovascular & Interventional Research Consultants, Inc. | Thermal balloon angioplasty |
JP3256540B2 (en) * | 1990-10-09 | 2002-02-12 | メッドトロニック・インコーポレイテッド | Device or device for manipulating the target object |
US5197978B1 (en) * | 1991-04-26 | 1996-05-28 | Advanced Coronary Tech | Removable heat-recoverable tissue supporting device |
FR2683449A1 (en) * | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5507767A (en) * | 1992-01-15 | 1996-04-16 | Cook Incorporated | Spiral stent |
WO1995014500A1 (en) * | 1992-05-01 | 1995-06-01 | Beth Israel Hospital | A stent |
PT703761E (en) * | 1993-03-11 | 2003-06-30 | Mark M Friedman | EXTENSOR |
US5480423A (en) * | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5913897A (en) * | 1993-09-16 | 1999-06-22 | Cordis Corporation | Endoprosthesis having multiple bridging junctions and procedure |
GB2281865B (en) * | 1993-09-16 | 1997-07-30 | Cordis Corp | Endoprosthesis having multiple laser welded junctions,method and procedure |
DE4334140C2 (en) * | 1993-10-07 | 1996-04-18 | Angiomed Ag | Stent and device with stent |
US5989280A (en) * | 1993-10-22 | 1999-11-23 | Scimed Lifesystems, Inc | Stent delivery apparatus and method |
JP2703510B2 (en) * | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
FR2714815B1 (en) * | 1994-01-10 | 1996-03-08 | Microfil Ind Sa | Elastic prosthesis to widen a duct, in particular a blood vessel. |
US6165213A (en) * | 1994-02-09 | 2000-12-26 | Boston Scientific Technology, Inc. | System and method for assembling an endoluminal prosthesis |
US5843120A (en) * | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US6165210A (en) * | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
ATE219343T1 (en) * | 1994-04-29 | 2002-07-15 | Scimed Life Systems Inc | STENT WITH COLLAGEN |
US5540701A (en) * | 1994-05-20 | 1996-07-30 | Hugh Sharkey | Passive fixation anastomosis method and device |
US5824041A (en) * | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
EP1051953A3 (en) * | 1994-06-17 | 2001-02-28 | Terumo Kabushiki Kaisha | Indwelling stent and the method for manufacturing the same |
US6015429A (en) * | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5545210A (en) * | 1994-09-22 | 1996-08-13 | Advanced Coronary Technology, Inc. | Method of implanting a permanent shape memory alloy stent |
WO1996012436A1 (en) * | 1994-10-20 | 1996-05-02 | Instent, Inc. | Cystoscope delivery system |
US5836964A (en) * | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
US5591226A (en) * | 1995-01-23 | 1997-01-07 | Schneider (Usa) Inc. | Percutaneous stent-graft and method for delivery thereof |
US5591197A (en) * | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
ATE232067T1 (en) * | 1995-04-14 | 2003-02-15 | Boston Scient Ltd | STENT DELIVERY DEVICE WITH ROLLING MEMBRANE |
CN1140227C (en) * | 1995-04-26 | 2004-03-03 | 梅迪诺尔有限公司 | Articulated stent |
US5591198A (en) * | 1995-04-27 | 1997-01-07 | Medtronic, Inc. | Multiple sinusoidal wave configuration stent |
US6010530A (en) * | 1995-06-07 | 2000-01-04 | Boston Scientific Technology, Inc. | Self-expanding endoluminal prosthesis |
US5649949A (en) * | 1996-03-14 | 1997-07-22 | Target Therapeutics, Inc. | Variable cross-section conical vasoocclusive coils |
US6039756A (en) * | 1996-04-26 | 2000-03-21 | Jang; G. David | Intravascular stent |
US6152957A (en) * | 1996-04-26 | 2000-11-28 | Jang; G. David | Intravascular stent |
US5669932A (en) * | 1996-05-29 | 1997-09-23 | Isostent, Inc. | Means for accurately positioning an expandable stent |
US5697971A (en) * | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5755781A (en) * | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5776142A (en) * | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
US6241757B1 (en) * | 1997-02-04 | 2001-06-05 | Solco Surgical Instrument Co., Ltd. | Stent for expanding body's lumen |
US5827321A (en) * | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5810872A (en) * | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
US5792144A (en) * | 1997-03-31 | 1998-08-11 | Cathco, Inc. | Stent delivery catheter system |
US5718713A (en) * | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
DE29708879U1 (en) * | 1997-05-20 | 1997-07-31 | Jomed Implantate GmbH, 72414 Rangendingen | Coronary stent |
US5891192A (en) * | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
BE1011180A6 (en) * | 1997-05-27 | 1999-06-01 | Medicorp R & D Benelux Sa | Luminal endoprosthesis AUTO EXPANDABLE. |
US5913895A (en) * | 1997-06-02 | 1999-06-22 | Isostent, Inc. | Intravascular stent with enhanced rigidity strut members |
EP0890346A1 (en) * | 1997-06-13 | 1999-01-13 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US5843175A (en) * | 1997-06-13 | 1998-12-01 | Global Therapeutics, Inc. | Enhanced flexibility surgical stent |
IL121316A (en) * | 1997-07-15 | 2001-07-24 | Litana Ltd | Implantable medical device of shape memory alloy |
WO1999015108A2 (en) * | 1997-09-24 | 1999-04-01 | Med Institute, Inc. | Radially expandable stent |
US6042606A (en) * | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US6071308A (en) * | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
US5961548A (en) * | 1997-11-18 | 1999-10-05 | Shmulewitz; Ascher | Bifurcated two-part graft and methods of implantation |
US6156062A (en) * | 1997-12-03 | 2000-12-05 | Ave Connaught | Helically wrapped interlocking stent |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6190406B1 (en) * | 1998-01-09 | 2001-02-20 | Nitinal Development Corporation | Intravascular stent having tapered struts |
US6077296A (en) * | 1998-03-04 | 2000-06-20 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6241762B1 (en) * | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6168621B1 (en) * | 1998-05-29 | 2001-01-02 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
US5911754A (en) * | 1998-07-24 | 1999-06-15 | Uni-Cath Inc. | Flexible stent with effective strut and connector patterns |
US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6093194A (en) * | 1998-09-14 | 2000-07-25 | Endocare, Inc. | Insertion device for stents and methods for use |
US5997563A (en) * | 1998-09-28 | 1999-12-07 | Medtronic, Inc. | Implantable stent having variable diameter |
US6042597A (en) * | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6059813A (en) * | 1998-11-06 | 2000-05-09 | Scimed Life Systems, Inc. | Rolling membrane stent delivery system |
US6190403B1 (en) * | 1998-11-13 | 2001-02-20 | Cordis Corporation | Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity |
US6251134B1 (en) * | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US6142987A (en) * | 1999-08-03 | 2000-11-07 | Scimed Life Systems, Inc. | Guided filter with support wire and methods of use |
US7141062B1 (en) * | 2000-03-01 | 2006-11-28 | Medinol, Ltd. | Longitudinally flexible stent |
US6468303B1 (en) * | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Retrievable self expanding shunt |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
IL137326A0 (en) * | 2000-07-17 | 2001-07-24 | Mind Guard Ltd | Implantable braided stroke preventing device and method of manufacturing |
AU2002219569B2 (en) * | 2001-01-15 | 2005-05-05 | Terumo Kabushiki Kaisha | Stent |
EP1364676A4 (en) * | 2001-02-01 | 2007-10-31 | Kaneka Corp | Stent |
US6878162B2 (en) * | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
CA2626717C (en) * | 2005-12-30 | 2014-10-21 | C.R. Bard Inc. | Stent with bio-resorbable connector and methods |
US7988723B2 (en) * | 2007-08-02 | 2011-08-02 | Flexible Stenting Solutions, Inc. | Flexible stent |
-
2010
- 2010-04-26 WO PCT/US2010/032427 patent/WO2010124286A1/en active Application Filing
- 2010-04-26 AU AU2010238636A patent/AU2010238636A1/en not_active Abandoned
- 2010-04-26 MX MX2011011209A patent/MX2011011209A/en unknown
- 2010-04-26 CA CA2759441A patent/CA2759441A1/en not_active Abandoned
- 2010-04-26 JP JP2012507471A patent/JP2012524641A/en active Pending
- 2010-04-26 NZ NZ595936A patent/NZ595936A/en unknown
- 2010-04-26 US US12/767,588 patent/US20100286760A1/en not_active Abandoned
- 2010-04-26 RU RU2011147113/14A patent/RU2011147113A/en not_active Application Discontinuation
- 2010-04-26 CN CN201080017811.2A patent/CN102413791B/en active Active
- 2010-04-26 KR KR1020117027875A patent/KR101314224B1/en active IP Right Grant
- 2010-04-26 BR BRPI1013573A patent/BRPI1013573A2/en not_active Application Discontinuation
- 2010-04-26 EP EP10767889.8A patent/EP2421470A4/en not_active Withdrawn
-
2012
- 2012-08-29 HK HK12108479.9A patent/HK1167798A1/en unknown
-
2014
- 2014-11-20 US US14/548,772 patent/US20150148887A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030195616A1 (en) * | 1994-03-17 | 2003-10-16 | Gregory Pinchasik | Articulated stent |
US5800526A (en) * | 1995-03-17 | 1998-09-01 | Endotex Interventional Systems, Inc. | Multi-anchor stent |
US6712842B1 (en) * | 1999-10-12 | 2004-03-30 | Allan Will | Methods and devices for lining a blood vessel and opening a narrowed region of a blood vessel |
US20040002753A1 (en) * | 2002-06-28 | 2004-01-01 | Robert Burgermeister | Stent with diagonal flexible connecting links |
WO2006108010A2 (en) | 2005-04-04 | 2006-10-12 | Burpee Materials Technology, Llc | Flexible stent |
US20070005126A1 (en) * | 2005-06-30 | 2007-01-04 | Boston Scientific Scimed, Inc. | Hybrid stent |
Non-Patent Citations (1)
Title |
---|
See also references of EP2421470A4 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9713522B2 (en) | 2011-10-31 | 2017-07-25 | Merit Medical Systems, Inc. | Esophageal stent with valve |
US9687367B2 (en) | 2012-06-05 | 2017-06-27 | Merit Medical Systems, Inc. | Esophageal stent |
EP2854718A4 (en) * | 2012-06-05 | 2016-02-24 | Merit Medical Systems Inc | Esophageal stent |
US11701246B2 (en) | 2012-11-15 | 2023-07-18 | Vactronix Scientific, Llc. | Stents having a hybrid pattern and methods of manufacture |
USD887003S1 (en) | 2012-11-15 | 2020-06-09 | Vactronix Scientific, Llc | Hybrid patterned stent device |
US10433989B2 (en) | 2012-11-15 | 2019-10-08 | Vactronix Scientific, Llc | Stents having a hybrid pattern and methods of manufacture |
US9566633B2 (en) | 2012-11-15 | 2017-02-14 | Vactronix Scientific, Inc. | Stents having a hybrid pattern and methods of manufacture |
US10143574B2 (en) | 2013-03-14 | 2018-12-04 | Vactronix Scientific, Llc | Monolithic medical devices, methods of making and using the same |
EP2967939A4 (en) * | 2013-03-14 | 2016-12-14 | Palmaz Scient Inc | Monolithic medical device, methods of making and using the same |
US11291569B2 (en) | 2013-03-14 | 2022-04-05 | Vactronix Scientific, Llc. | Monolithic medical devices, methods of making and using the same |
US9700401B2 (en) | 2013-09-12 | 2017-07-11 | Boston Scientific Scimed, Inc. | Stent with anti-migration connectors |
USD888245S1 (en) | 2014-03-14 | 2020-06-23 | Vactronix Scientific, Llc | Stent device |
WO2016037115A1 (en) * | 2014-09-04 | 2016-03-10 | Boston Scientific Scimed, Inc. | Bioerodible polymeric stent scaffolding pattern |
US11590008B2 (en) | 2014-10-02 | 2023-02-28 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
US10219921B2 (en) | 2014-10-02 | 2019-03-05 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
WO2016065086A1 (en) * | 2014-10-22 | 2016-04-28 | Boston Scientific Scimed, Inc. | Stent with flexible hinge |
KR101949065B1 (en) | 2014-10-22 | 2019-02-15 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | Stent with flexible hinge |
US10130498B2 (en) | 2014-10-22 | 2018-11-20 | Boston Scientific Scimed, Inc. | Stent with flexible hinge |
US10898354B2 (en) | 2014-11-06 | 2021-01-26 | Boston Scientific Scimed, Inc. | Tracheal stent |
EP3763340A1 (en) * | 2016-03-24 | 2021-01-13 | Covidien LP | Vascular flow diversion |
WO2017165840A1 (en) * | 2016-03-24 | 2017-09-28 | Covidien Lp | Vascular flow diversion |
US11759341B2 (en) | 2020-01-13 | 2023-09-19 | Boston Scientific Scimed, Inc. | Anti-migration stent |
Also Published As
Publication number | Publication date |
---|---|
EP2421470A1 (en) | 2012-02-29 |
KR101314224B1 (en) | 2013-10-04 |
CA2759441A1 (en) | 2010-10-28 |
JP2012524641A (en) | 2012-10-18 |
BRPI1013573A2 (en) | 2016-04-12 |
NZ595936A (en) | 2014-06-27 |
AU2010238636A1 (en) | 2011-11-17 |
US20100286760A1 (en) | 2010-11-11 |
CN102413791B (en) | 2014-10-29 |
EP2421470A4 (en) | 2016-03-30 |
HK1167798A1 (en) | 2012-12-14 |
US20150148887A1 (en) | 2015-05-28 |
RU2011147113A (en) | 2013-05-27 |
KR20120018772A (en) | 2012-03-05 |
MX2011011209A (en) | 2012-04-19 |
CN102413791A (en) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150148887A1 (en) | Flexible devices | |
US9592137B2 (en) | Flexible stent | |
US7988723B2 (en) | Flexible stent | |
US20150039072A1 (en) | Flexible stent | |
AU2012201649B2 (en) | Flexible stent | |
AU2014201135B2 (en) | Flexible stent | |
AU2015255219A1 (en) | Flexible devices | |
ES2937954T3 (en) | flexible stent | |
NZ588872A (en) | Self expanding flexible stent comprising a helical strut member and multiple helical elements | |
MX2007012271A (en) | Flexible stent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080017811.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10767889 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2759441 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012507471 Country of ref document: JP |
|
REEP | Request for entry into the european phase |
Ref document number: 2010767889 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2011/011209 Country of ref document: MX Ref document number: 2010767889 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 595936 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2010238636 Country of ref document: AU Date of ref document: 20100426 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20117027875 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2011147113 Country of ref document: RU Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1013573 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1013573 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111021 |